MARATTO

article · Veterinary Medicine and Science

Antimicrobial Susceptibility Profiles of Extended‐Spectrum <i>β</i> ‐Lactamase‐Producing <i>Escherichia coli</i> Isolated From Intensively Reared and Free‐Range Chickens in Selected Districts of Zambia

2026Open accessUniversity of Zambia

Abstract

ABSTRACT Background Extended‐spectrum β ‐lactamase (ESBL)‐producing Escherichia coli in poultry is an emerging One Health concern, yet comparative data on intensive versus free‐range systems in sub‐Saharan Africa remain sparse. Objectives To compare the prevalence, susceptibility profiles and β ‐lactamase gene content of ESBL‐producing E. coli from intensively reared and free‐range chickens in Central Province, Zambia. Methods In a cross‐sectional study (March–April 2021), 112 pooled faecal samples (56 per production system; 10 birds per sampling point) were collected across seven veterinary camps in Kabwe and Kapiri Mposhi districts and processed within 24 h. Presumptive ESBL E. coli was isolated on MacConkey agar with 2 mg/L cefotaxime and identified biochemically. Susceptibility to 11 antimicrobials was tested by Kirby–Bauer disc diffusion per CLSI M100 (2020), and ESBL production was confirmed by combination‐disc synergy. bla CTX‐M , bla TEM and bla SHV were detected by multiplex PCR. Proportions were compared using Fisher's exact test with 95% Wilson confidence intervals (CIs). Results ESBL‐producing E. coli was recovered from 13/112 pooled samples (11.6%, 95% CI: 6.9%–18.9%), with no difference between intensively reared (7/56, 12.5%) and free‐range (6/56, 10.7%) chickens ( p = 1.00). All 13 isolates were multidrug‐resistant, with the highest resistance to tetracycline and cefotaxime (both 100%), streptomycin (84.6%) and sulfamethoxazole–trimethoprim (69.2%). bla CTX‐M was present in all 13 isolates, bla TEM in 4 (30.8%) and bla SHV in 1 (7.7%), with co‐carriage in 5 isolates. Conclusions Multidrug‐resistant, bla CTX‐M ‐driven ESBL E. coli circulates at comparable levels in both production systems, consistent with environmental dissemination. Integrated One Health surveillance and antimicrobial stewardship are warranted.

Research topics

  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • Pharmaceutical and Antibiotic Environmental Impacts

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/vms3.71090

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.